Sooma Oy is developing, manufacturing and marketing a non-invasive therapy device for neurological and psychiatric disorders (depression and chronic pain). Sooma uses transcranial direct current stimulation (tDCS) technology.
Sooma technology is trusted by over 100 clinics worldwide. Their first product is the first portable device approved for treatment of major depressive disorder (MDD). The device is CE-approved and currently marketed in the EU and other selected markets. Their quality management system has been awarded with ISO 13485:2016 and MDSAP certificates.
Date of investment December, 2019
Offices Helsinki, Finland
Tuomas Neuvonen
CEO & Co-Founder
Mika Nikander
COO
